Disease burden and risk profile in referred patients with moderate chronic kidney disease: Composition of the German Chronic Kidney Disease (GCKD) cohort

Nephrology Dialysis Transplantation

Volumn 30, Issue 3, 2015, Pages 441-451

  Titze, Stephanie ^a   Schmid, Matthias ^a,b   Köttgen, Anna ^c   Busch, Martin ^d   Floege, Jürgen ^e   Wanner, Christoph ^f   Kronenberg, Florian ^g   Eckardt, Kai Uwe ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

cardiovascular disease; chronic kidney disease; epidemiology; nephrology referral

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; RENIN INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GERMANY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; SMOKING; AGED; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMORBIDITY; COMPLICATION; DIABETIC NEPHROPATHIES; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PATIENT REFERRAL; PROGNOSIS;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DIABETIC NEPHROPATHIES; FEMALE; GERMANY; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; REFERRAL AND CONSULTATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84924410980     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu294     Document Type: Article

References (50)

1. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180
2. Eckardt KU, Coresh J, Devuyst O et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013; 382: 158-169
3. KDIGO (Kidney Disease: Improving Global Outcomes). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150
4. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339-352
5. Palmer SC, Sciancalepore M, Strippoli GF. Trial quality in nephrology: how are we measuring up? Am J Kid Dis 2011; 58: 335-337
6. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
7. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
8. Winkelmayer WC, Owen WF, Jr, Levin R et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14: 486-492
9. Owen WF, Jr. Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol 2003; 14(7 Suppl 2): S76-S80
10. Rucker D, Hemmelgarn BR, Lin M et al. Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int 2011; 79: 210-217
11. Feldman HI, Appel LJ, Chertow GM et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14(7 Suppl 2): S148-S153
12. Lash JP, Go AS, Appel LJ et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 2009; 4: 1302-1311
13. Imai E, Matsuo S, Makino H et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010; 14: 558-570
14. Kronenberg F, Kuen E, Ritz E et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105-115
15. Landray MJ, Emberson JR, Blackwell L et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 2010; 56: 1082-1094
16. Hoefield RA, Kalra PA, Baker P et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis 2010; 56: 1072-1081
17. Martinez-Castelao A, Gorriz JL, Portoles JM et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol 2011; 12: 53
18. Levin A, Rigatto C, Brendan B et al. Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT). BMC Nephrol 2013; 14: 121
19. Eckardt KU, Barthlein B, Baid-Agrawal S et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant 2012; 27: 1454-1460
20. Levey AS, Greene T, Beck GJ et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 1999; 10: 2426-2439
21. Hays RD, Kallich JD, Mapes DL et al. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3: 329-338
22. Avery CL, Mills KT, Chambless LE et al. Long-term association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study. Eur J Heart Fail 2010; 12: 232-238
23. Lallukka T, Manderbacka K, Keskimaki I et al. Angina pectoris: relation of epidemiological survey to registry data. Eur J Cardiovasc Prev Rehab 2011; 18: 621-626
24. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109
25. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
26. Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20-29
27. Prokosch HU, Mate S, Christoph J et al. Designing and implementing a biobanking IT framework for multiple research scenarios. Stud Health Technol Inform 2012; 180: 559-563
28. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28.
29. de Boer IH, Rue TC, Cleary PA et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011; 171: 412-420
30. Zoppini G, Targher G, Chonchol M et al. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol 2012; 7: 401-408
31. Zhang QL, Koenig W, Raum E et al. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009; 48: 122-127
32. Aumann N, Baumeister SE, Werner A et al. Inverse association of estimated cystatin C-and creatinine-based glomerular filtration rate with left ventricular mass: Results from the Study of Health in Pomerania. Int J Cardiol 2013; 167: 2786-2791
33. Kuznik A, Mardekian J, Tarasenko L. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010. BMC Nephrol 2013; 14: 132
34. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789
35. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
36. Baumeister SE, Boger CA, Kramer BK et al. Effect of chronic kidney disease and comorbid conditions on health care costs: a 10-year observational study in a general population. Am J Nephrol 2010; 31: 222-229
37. Grams ME, Chow EK, Segev DL et al. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013; 62: 245-252
38. Dittmann K, Hannemann A, Wallaschofski H et al. U-shaped association between central body fat and the urinary albumin-to-creatinine ratio and microalbuminuria. BMC Nephrol 2013; 14: 87
39. Kleophas W, Bieber B, Robinson BM et al. Implementation and first results of a German chronic kidney disease registry. Clin Nephrol 2013; 79: 184-191
40. Heid IM, Vollmert C, Hinney A et al. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 2005; 42: e21
41. Briffa JF, McAinch AJ, Poronnik P et al. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol 201; 305: F1629-F1636
42. Alicic RZ, Patakoti R, Tuttle KR. Direct and indirect effects of obesity on the kidney. Adv Chronic Kidney Dis 2013; 20: 121-127
43. Odoni G, Ogata H, Viedt C et al. Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 2002; 61: 2090-2098
44. Lei HH, Perneger TV, Klag MJ et al. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 1998; 9: 1270-1276
45. Freedman BI, Volkova NV, Satko SG et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 2005; 25: 529-535
46. Kottgen A, Pattaro C, Boger CA et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42: 376-384
47. Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009; 5: 677-689
48. KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guidelines for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl 2012; 2: 1-414
49. Kovesdy CP, Bleyer AJ, Molnar MZ et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 2013; 159: 233-242
50. Raum E, Lietzau S, Stegmaier C et al. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 2008; 17: 485-494